Literature DB >> 17458495

Interleukin-1 alpha polymorphism has influence on late-onset sporadic Parkinson's disease in Taiwan.

Y R Wu1, C M Chen, J C Hwang, S T Chen, I H Feng, H C Hsu, C N Liu, Y T Liu, Y Y Lai, H J Huang, G J Lee-Chen.   

Abstract

Inflammatory events may contribute to the pathogenesis of Parkinson's disease (PD) and interleukin 1 (IL-1) may exert both neurotoxic and neuroprotective effects. We conducted a case-control study in a cohort of 493 PD cases and 388 ethnically matched controls to investigate the association of IL-1alpha C-889T and IL-1beta C-511T polymorphisms with the risk of PD. No significant difference in the genotype distribution of the analyzed polymorphisms was found between PD and controls. However, after stratification by age, individuals over 70 years of age carrying IL-1alpha-889 C/T genotype demonstrated a significant decrease in risk of developing PD (OR = 0.44; 95% CI = 0.22-0.88, p = 0.021) and the decrease is strengthened by IL-1beta-511 T-carrying genotype (OR = 0.28; 95% CI = 0.11-0.71, p = 0.008). Our data suggest that IL-1alpha, acting synergistically with IL-1beta, plays role in PD susceptibility among Taiwanese people older than 70 years of age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458495     DOI: 10.1007/s00702-007-0726-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  47 in total

1.  Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.

Authors:  Y Du; R C Dodel; B J Eastwood; K R Bales; F Gao; F Lohmüller; U Müller; A Kurz; R Zimmer; R M Evans; A Hake; T Gasser; W H Oertel; W S Griffin; S M Paul; M R Farlow
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

2.  Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients.

Authors:  K M Mattila; J O Rinne; T Lehtimäki; M Röyttä; J P Ahonen; M Hurme
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

3.  Molecular cloning of the interleukin-1 gene cluster: construction of an integrated YAC/PAC contig and a partial transcriptional map in the region of chromosome 2q13.

Authors:  H G Nothwang; B Strahm; D Denich; M Kübler; J Schwabe; J C Gingrich; A Jauch; A Cox; M J Nicklin; D M Kurnit; F Hildebrandt
Journal:  Genomics       Date:  1997-05-01       Impact factor: 5.736

4.  Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

Authors:  D H Gabuzda; D D Ho; S M de la Monte; M S Hirsch; T R Rota; R A Sobel
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

5.  Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

Authors:  B O Evert; I R Vogt; C Kindermann; L Ozimek; R A de Vos; E R Brunt; I Schmitt; T Klockgether; U Wüllner
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease.

Authors:  Masataka Nishimura; Sadako Kuno; Ryuji Kaji; Katsuhito Yasuno; Hideshi Kawakami
Journal:  Mov Disord       Date:  2005-07       Impact factor: 10.338

Review 7.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Authors:  Yoon Seong Kim; Tong H Joh
Journal:  Exp Mol Med       Date:  2006-08-31       Impact factor: 8.718

8.  The pathogenesis of cell death in Parkinson's disease.

Authors:  Peter Jenner; C Warren Olanow
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

9.  Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease.

Authors:  A Ho; M Blum
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

10.  Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.

Authors:  J Wang; K S Bankiewicz; R J Plunkett; E H Oldfield
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more
  4 in total

Review 1.  Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.

Authors:  Heather E Allen Reish; David G Standaert
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

2.  The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Malak G Kolta; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2017-09-20       Impact factor: 3.478

Review 3.  The role of inflammation in sporadic and familial Parkinson's disease.

Authors:  Michela Deleidi; Thomas Gasser
Journal:  Cell Mol Life Sci       Date:  2013-05-12       Impact factor: 9.261

Review 4.  Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?

Authors:  Christopher J Barnum; Malú G Tansey
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.